1,4-phenylenebis(methylene)selenocyanate has been researched along with selenomethionine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, S; Desai, DH; El-Bayoumy, K; Kurtzke, C; Prokopczyk, B; Upadhyaya, P | 1 |
| El-Bayoumy, K; Facompre, ND; Pinto, JT; Sinha, R; Sun, YW | 1 |
| Cassidy, PB; Li, L; Roberts, JC; Short, MD; Xie, Y | 1 |
3 other study(ies) available for 1,4-phenylenebis(methylene)selenocyanate and selenomethionine
| Article | Year |
|---|---|
Effects of 1,4-phenylenebis(methylene)selenocyanate and selenomethionine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung.
Topics: Animals; Anticarcinogenic Agents; Disease Models, Animal; Female; Lung Neoplasms; Mice; Nitrosamines; Organoselenium Compounds; Selenomethionine; Smoking | 1997 |
1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.
Topics: Androgen Antagonists; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Evaluation, Preclinical; Humans; Male; Models, Biological; Oncogene Protein v-akt; Organoselenium Compounds; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Receptors, Androgen; Selenomethionine; Signal Transduction; Tumor Cells, Cultured | 2010 |
Characteristics of selenazolidine prodrugs of selenocysteine: toxicity and glutathione peroxidase induction in V79 cells.
Topics: Animals; Cricetinae; Cricetulus; Enzyme Induction; Glutathione Peroxidase; Organoselenium Compounds; Prodrugs; Proline; Selenocysteine; Stereoisomerism; Structure-Activity Relationship | 2003 |